Bruno Sepodes holds a PhD in Pharmacy (Pharmacology) by the University of Lisbon. Currently a Professor of Pharmacology and Pharmacotherapy at the Faculty of Pharmacy of the University of Lisbon, he develops his research in Pharmacology and Translational Medicine. Presently Prof. Sepodes is the Chair of the Committee for Orphan Medicinal Products (COMP) and member of the Committee of Human Medicinal Products (CHMP) and of the Committee of Advanced Therapies (CAT) at the European Medicines Agency in London. His collaboration with the European Medicines Agency started as a member of the COMP in 2008 and followed as a member of the Patients’ and Consumers Working Party during 2012. Bruno Sepodes is an expert for the National Medicines Authority (INFARMED) and for the Veterinary General Directorate (DGV). Concerning the involvement in research projects, international collaborations include collaboration with the William Harvey Research Institute (UK) and other relevant research institutes. He is author and co-author of more than 70 scientific publications in international journals, and more than 100 scientific communications (on pharmacology, toxicology and therapeutics), presented to national and international scientific meetings. Areas of expertise include: orphan medicinal products development and evaluation; pharmacology of inflammation; human medicines evaluation, general and special toxicology and non-clinical drug development.